Genzyme plant goes idle for sanitizing

Genzyme is temporarily halting drug production at its Allston, MA, plant due to viral contamination in a bioreactor. Though the virus is not known to be a threat to humans, production will cease for the facility to be sanitized. Genzyme expects the plant to be operational by the end of July. Report

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.